These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 17135585)

  • 1. Financial relationships between institutional review board members and industry.
    Campbell EG; Weissman JS; Vogeli C; Clarridge BR; Abraham M; Marder JE; Koski G
    N Engl J Med; 2006 Nov; 355(22):2321-9. PubMed ID: 17135585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Industry Relationships Among Academic Institutional Review Board Members: Changes From 2005 Through 2014.
    Campbell EG; Vogeli C; Rao SR; Abraham M; Pierson R; Applebaum S
    JAMA Intern Med; 2015 Sep; 175(9):1500-6. PubMed ID: 26168043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opinions of IRB Members and Chairs Regarding Investigators' Relationships with Industry.
    Weissman JS; Koski G; Vogeli C; Thiessen C; Campbell EG
    J Empir Res Hum Res Ethics; 2008 Mar; 3(1):3-13. PubMed ID: 19385778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Financial relationships of institutional review board members.
    Miller FG
    N Engl J Med; 2007 Mar; 356(9):965; author reply 965. PubMed ID: 17329710
    [No Abstract]   [Full Text] [Related]  

  • 5. Patients' views on financial conflicts of interest in cancer research trials.
    Hampson LA; Agrawal M; Joffe S; Gross CP; Verter J; Emanuel EJ
    N Engl J Med; 2006 Nov; 355(22):2330-7. PubMed ID: 17135586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Conflict-of-interest" and participation in IRB deliberations: an alternative perspective.
    Markman M
    Cancer Invest; 2008 Mar; 26(2):115-7. PubMed ID: 18259940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conflict-of-interest policies for investigators in clinical trials.
    Lo B; Wolf LE; Berkeley A
    N Engl J Med; 2000 Nov; 343(22):1616-20. PubMed ID: 11096170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A national survey of policies on disclosure of conflicts of interest in biomedical research.
    McCrary SV; Anderson CB; Jakovljevic J; Khan T; McCullough LB; Wray NP; Brody BA
    N Engl J Med; 2000 Nov; 343(22):1621-6. PubMed ID: 11096171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships between academic institutions and industry in the life sciences--an industry survey.
    Blumenthal D; Causino N; Campbell E; Louis KS
    N Engl J Med; 1996 Feb; 334(6):368-73. PubMed ID: 8538709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Policies and management of conflicts of interest within medical research institutional review boards: results of a national study.
    Vogeli C; Koski G; Campbell EG
    Acad Med; 2009 Apr; 84(4):488-94. PubMed ID: 19318786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conflict of interest--or conflict of priorities?
    Nabel EG
    N Engl J Med; 2006 Nov; 355(22):2365-7. PubMed ID: 17135592
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinician educators' experiences with institutional review boards: results of a national survey.
    Dyrbye LN; Thomas MR; Papp KK; Durning SJ
    Acad Med; 2008 Jun; 83(6):590-5. PubMed ID: 18520468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Industry-sponsored research.
    Okike K; Kocher MS; Mehlman CT; Bhandari M
    Injury; 2008 Jun; 39(6):666-80. PubMed ID: 18508054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A qualitative study of institutional review board members' experience reviewing research proposals using emergency exception from informed consent.
    McClure KB; Delorio NM; Schmidt TA; Chiodo G; Gorman P
    J Med Ethics; 2007 May; 33(5):289-93. PubMed ID: 17470507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Responses of medical schools to institutional conflicts of interest.
    Ehringhaus SH; Weissman JS; Sears JL; Goold SD; Feibelmann S; Campbell EG
    JAMA; 2008 Feb; 299(6):665-71. PubMed ID: 18270355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Participation of life-science faculty in research relationships with industry.
    Blumenthal D; Campbell EG; Causino N; Louis KS
    N Engl J Med; 1996 Dec; 335(23):1734-9. PubMed ID: 8929266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protecting subjects, preserving trust, promoting progress I: policy and guidelines for the oversight of individual financial interests in human subjects research.
    AAMC Task Force on Financial Conflicts of Interest in Clinical Research
    Acad Med; 2003 Feb; 78(2):225-36. PubMed ID: 12584106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conflicts of interest and disclosure in the American Psychiatric Association's Clinical Practice Guidelines.
    Cosgrove L; Bursztajn HJ; Krimsky S; Anaya M; Walker J
    Psychother Psychosom; 2009; 78(4):228-32. PubMed ID: 19401623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of conflict-of-interest disclosures reported by physicians.
    Okike K; Kocher MS; Wei EX; Mehlman CT; Bhandari M
    N Engl J Med; 2009 Oct; 361(15):1466-74. PubMed ID: 19812403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Members of the same club": challenges and decisions faced by US IRBs in identifying and managing conflicts of interest.
    Klitzman R
    PLoS One; 2011; 6(7):e22796. PubMed ID: 21829516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.